For chronic pain sufferers, there is a real problem with the abuse of painkillers in the United States. While the number of patients who have a legitimate need for prescription painkillers — 100 million plus — is vastly more than the number of people addicted to painkillers — 11 million — there is a stigma attached to the prescribing, dispensing and utilization of pain medicines.
Walgreens will install safe medication disposal kiosks in more than 500 drug stores in 39 states and make naloxon available without a prescription at its pharmacies in 35 states.
As part of its annual Industry Issues Conference in December, Drug Store News hosted the Chronic Care and Retail Health Roundtable, expanding the program for the first time in its 15 year-existence beyond the diabetes management.
The Food and Drug Administration has approved Narcan, a nasal spray dose of naloxone, which is typically administered via injection.
PUTTING A FACE ON PAIN MANAGEMENT
Chronic pain sufferer Dennis Kinch pens book to encourage pain community
Ehlers-Danlos Syndrome patient Ellen Smith serves as advocate for pain relief
Gina Libby strives to improve pain medication legislation
Former radio personality Radene Marie Cook rues 'fail first' treatment plans
HealthDay is reporting that researchers fromt the University of Michigan’s Survey Research Center have found that a person’s use of narcotic painkillers as a teen raises their risk of abuse as an adult by 33%. “Most likely, the initial experience of pain relief is pleasurable and a safe initial experience may reduce perceived danger,” the study’s author Richard Miech said. “A pleasurable and safe initial experience with a drug is a central factor in theories of who goes on to misuse drugs.” (HealthDay)
Using 2013 data from state prescription drug monitoring programs from eight states, the CDC found that prescribing practices between states vary drastically.
With an estimated 60 million people in the United States experiencing heartburn at least once a month, and more than 15 million suffering from it daily, products to treat the condition have become more sophisticated, and the battle for supremacy in the $2.18 billion-a-year antacid tablets market has grown more heated.
The New York Times outlines the controversy surrounding the recent FDA approval of Oxycontin in children. “Just because OxyContin has been abused or prescribed inappropriately doesn’t mean we should deprive the children who need the drug,” Kathleen Neville, pediatric oncologist at Arkansas Children's Hospital told The New York Times, adding it is “our obligation to have the best level of evidence for its use in children.” (The New York Times)
According to CBS Miami, the Florida Board of Pharmacy has adopted a rule change that looks to help pharmacists ensure that patients who need prescribed controlled substances can get them. “Instead of starting out with trying to find a reason to doubt a prescription, you start off with an assumption that everything in the prescription is good, and you work towards achieving patient access,” Florida Pharmacy Association EVP Michael Jackson said. (CBS Miami)
More than 80% of Americans support medical school and physician residency programs to provide training for physicians in how to treat chronic pain and how to detect and treat addiction to prescription pain medication.